Copyright Reports & Markets. All rights reserved.

Global and China Angiopoietin 2 Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Angiopoietin 2 Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Angiopoietin 2 Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Angiopoietin 2 Market Size Growth Rate by Type
    • 1.4.2 Atu-111
    • 1.4.3 BI-836880
    • 1.4.4 LY-3127804
    • 1.4.5 MEDI-3617
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Angiopoietin 2 Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Angiopoietin 2 Market Size, Estimates and Forecasts
    • 2.1.1 Global Angiopoietin 2 Revenue 2015-2026
    • 2.1.2 Global Angiopoietin 2 Sales 2015-2026
  • 2.2 Global Angiopoietin 2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Angiopoietin 2 Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Angiopoietin 2 Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Angiopoietin 2 Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Angiopoietin 2 Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Angiopoietin 2 Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Angiopoietin 2 Revenue Forecast by Region (2021-2026)

3 Global Angiopoietin 2 Competitor Landscape by Players

  • 3.1 Global Top Angiopoietin 2 Sales by Manufacturers
    • 3.1.1 Global Angiopoietin 2 Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Angiopoietin 2 Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Angiopoietin 2 Manufacturers by Revenue
    • 3.2.1 Global Angiopoietin 2 Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Angiopoietin 2 Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Angiopoietin 2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Angiopoietin 2 Revenue in 2019
    • 3.2.5 Global Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Angiopoietin 2 Price by Manufacturers
  • 3.4 Global Angiopoietin 2 Manufacturing Base Distribution, Product Types
    • 3.4.1 Angiopoietin 2 Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Angiopoietin 2 Product Type
    • 3.4.3 Date of International Manufacturers Enter into Angiopoietin 2 Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Angiopoietin 2 Market Size by Type (2015-2020)
    • 4.1.1 Global Angiopoietin 2 Sales by Type (2015-2020)
    • 4.1.2 Global Angiopoietin 2 Revenue by Type (2015-2020)
    • 4.1.3 Angiopoietin 2 Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Angiopoietin 2 Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Angiopoietin 2 Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Angiopoietin 2 Revenue Forecast by Type (2021-2026)
    • 4.2.3 Angiopoietin 2 Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Angiopoietin 2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Angiopoietin 2 Market Size by Application (2015-2020)
    • 5.1.1 Global Angiopoietin 2 Sales by Application (2015-2020)
    • 5.1.2 Global Angiopoietin 2 Revenue by Application (2015-2020)
    • 5.1.3 Angiopoietin 2 Price by Application (2015-2020)
  • 5.2 Angiopoietin 2 Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Angiopoietin 2 Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Angiopoietin 2 Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Angiopoietin 2 Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

  • 6.1 China Angiopoietin 2 Market Size YoY Growth 2015-2026
    • 6.1.1 China Angiopoietin 2 Sales YoY Growth 2015-2026
    • 6.1.2 China Angiopoietin 2 Revenue YoY Growth 2015-2026
    • 6.1.3 China Angiopoietin 2 Market Share in Global Market 2015-2026
  • 6.2 China Angiopoietin 2 Market Size by Players (International and Local Players)
    • 6.2.1 China Top Angiopoietin 2 Players by Sales (2015-2020)
    • 6.2.2 China Top Angiopoietin 2 Players by Revenue (2015-2020)
  • 6.3 China Angiopoietin 2 Historic Market Review by Type (2015-2020)
    • 6.3.1 China Angiopoietin 2 Sales Market Share by Type (2015-2020)
    • 6.3.2 China Angiopoietin 2 Revenue Market Share by Type (2015-2020)
    • 6.3.3 China Angiopoietin 2 Price by Type (2015-2020)
  • 6.4 China Angiopoietin 2 Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 China Angiopoietin 2 Sales Forecast by Type (2021-2026)
    • 6.4.2 China Angiopoietin 2 Revenue Forecast by Type (2021-2026)
    • 6.4.3 China Angiopoietin 2 Price Forecast by Type (2021-2026)
  • 6.5 China Angiopoietin 2 Historic Market Review by Application (2015-2020)
    • 6.5.1 China Angiopoietin 2 Sales Market Share by Application (2015-2020)
    • 6.5.2 China Angiopoietin 2 Revenue Market Share by Application (2015-2020)
    • 6.5.3 China Angiopoietin 2 Price by Application (2015-2020)
  • 6.6 China Angiopoietin 2 Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 China Angiopoietin 2 Sales Forecast by Application (2021-2026)
    • 6.6.2 China Angiopoietin 2 Revenue Forecast by Application (2021-2026)
    • 6.6.3 China Angiopoietin 2 Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Angiopoietin 2 Market Size YoY Growth 2015-2026
  • 7.2 North America Angiopoietin 2 Market Facts & Figures by Country
    • 7.2.1 North America Angiopoietin 2 Sales by Country (2015-2020)
    • 7.2.2 North America Angiopoietin 2 Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Angiopoietin 2 Market Size YoY Growth 2015-2026
  • 8.2 Europe Angiopoietin 2 Market Facts & Figures by Country
    • 8.2.1 Europe Angiopoietin 2 Sales by Country
    • 8.2.2 Europe Angiopoietin 2 Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Angiopoietin 2 Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Angiopoietin 2 Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Angiopoietin 2 Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Angiopoietin 2 Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Angiopoietin 2 Market Size YoY Growth 2015-2026
  • 10.2 Latin America Angiopoietin 2 Market Facts & Figures by Country
    • 10.2.1 Latin America Angiopoietin 2 Sales by Country
    • 10.2.2 Latin America Angiopoietin 2 Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Angiopoietin 2 Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Angiopoietin 2 Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Angiopoietin 2 Sales by Country
    • 11.2.2 Middle East and Africa Angiopoietin 2 Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Amgen Inc.
    • 12.1.1 Amgen Inc. Corporation Information
    • 12.1.2 Amgen Inc. Description and Business Overview
    • 12.1.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Amgen Inc. Angiopoietin 2 Products Offered
    • 12.1.5 Amgen Inc. Recent Development
  • 12.2 AnGes MG, Inc.
    • 12.2.1 AnGes MG, Inc. Corporation Information
    • 12.2.2 AnGes MG, Inc. Description and Business Overview
    • 12.2.3 AnGes MG, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 AnGes MG, Inc. Angiopoietin 2 Products Offered
    • 12.2.5 AnGes MG, Inc. Recent Development
  • 12.3 Boehringer Ingelheim GmbH
    • 12.3.1 Boehringer Ingelheim GmbH Corporation Information
    • 12.3.2 Boehringer Ingelheim GmbH Description and Business Overview
    • 12.3.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Products Offered
    • 12.3.5 Boehringer Ingelheim GmbH Recent Development
  • 12.4 Eli Lilly and Company
    • 12.4.1 Eli Lilly and Company Corporation Information
    • 12.4.2 Eli Lilly and Company Description and Business Overview
    • 12.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Eli Lilly and Company Angiopoietin 2 Products Offered
    • 12.4.5 Eli Lilly and Company Recent Development
  • 12.5 F. Hoffmann-La Roche Ltd.
    • 12.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
    • 12.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
    • 12.5.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Products Offered
    • 12.5.5 F. Hoffmann-La Roche Ltd. Recent Development
  • 12.6 MedImmune, LLC
    • 12.6.1 MedImmune, LLC Corporation Information
    • 12.6.2 MedImmune, LLC Description and Business Overview
    • 12.6.3 MedImmune, LLC Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 MedImmune, LLC Angiopoietin 2 Products Offered
    • 12.6.5 MedImmune, LLC Recent Development
  • 12.7 Regeneron Pharmaceuticals, Inc.
    • 12.7.1 Regeneron Pharmaceuticals, Inc. Corporation Information
    • 12.7.2 Regeneron Pharmaceuticals, Inc. Description and Business Overview
    • 12.7.3 Regeneron Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Products Offered
    • 12.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
  • 12.8 RXi Pharmaceuticals Corporation
    • 12.8.1 RXi Pharmaceuticals Corporation Corporation Information
    • 12.8.2 RXi Pharmaceuticals Corporation Description and Business Overview
    • 12.8.3 RXi Pharmaceuticals Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Products Offered
    • 12.8.5 RXi Pharmaceuticals Corporation Recent Development
  • 12.9 Silence Therapeutics Plc
    • 12.9.1 Silence Therapeutics Plc Corporation Information
    • 12.9.2 Silence Therapeutics Plc Description and Business Overview
    • 12.9.3 Silence Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Silence Therapeutics Plc Angiopoietin 2 Products Offered
    • 12.9.5 Silence Therapeutics Plc Recent Development
  • 12.10 Synergys Biotherapeutics, Inc.
    • 12.10.1 Synergys Biotherapeutics, Inc. Corporation Information
    • 12.10.2 Synergys Biotherapeutics, Inc. Description and Business Overview
    • 12.10.3 Synergys Biotherapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Products Offered
    • 12.10.5 Synergys Biotherapeutics, Inc. Recent Development
  • 12.11 Amgen Inc.
    • 12.11.1 Amgen Inc. Corporation Information
    • 12.11.2 Amgen Inc. Description and Business Overview
    • 12.11.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Amgen Inc. Angiopoietin 2 Products Offered
    • 12.11.5 Amgen Inc. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Angiopoietin 2 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Angiopoietin 2 Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Angiopoietin 2 market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Angiopoietin 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Angiopoietin 2 market is segmented into
    Atu-111
    BI-836880
    LY-3127804
    MEDI-3617
    Others

    Segment by Application, the Angiopoietin 2 market is segmented into
    Hospital
    Clinic
    Others

    Regional and Country-level Analysis
    The Angiopoietin 2 market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Angiopoietin 2 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Angiopoietin 2 Market Share Analysis
    Angiopoietin 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiopoietin 2 business, the date to enter into the Angiopoietin 2 market, Angiopoietin 2 product introduction, recent developments, etc.
    The major vendors covered:
    Amgen Inc.
    AnGes MG, Inc.
    Boehringer Ingelheim GmbH
    Eli Lilly and Company
    F. Hoffmann-La Roche Ltd.
    MedImmune, LLC
    Regeneron Pharmaceuticals, Inc.
    RXi Pharmaceuticals Corporation
    Silence Therapeutics Plc
    Synergys Biotherapeutics, Inc.

    Buy now